Growth factors

Neurological Sciences

Volumn 24, Issue SUPPL. 5, 2003, Pages

  Aloisi, F ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Glial cells; Growth factors; Multiple sclerosis; Neuroprotection; Remyelination

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; BASIC FIBROBLAST GROWTH FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; GROWTH FACTOR; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; NERVE GROWTH FACTOR; NEU DIFFERENTIATION FACTOR; NEURITE PROMOTING FACTOR; NEUROTROPHIN; NEUROTROPHIN 3; NEUROTROPHIN 4; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN C;

ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; DEMYELINATING DISEASE; MOLECULAR DYNAMICS; MULTIPLE SCLEROSIS; MYELINATION; NERVE CELL DIFFERENTIATION; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; PROTEIN FAMILY; PROTEIN FUNCTION; REMYELINIZATION; SYMPTOMATOLOGY;

ANIMALS; CENTRAL NERVOUS SYSTEM; GROWTH SUBSTANCES; HUMANS; MULTIPLE SCLEROSIS; NERVE REGENERATION; NEURONS; OLIGODENDROGLIA; STEM CELLS;

EID: 0344308229     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-003-0177-0     Document Type: Article

References (16)

1. Stangel M, Hartung HP (2002) Remyelinating strategies for the treatment of multiple sclerosis. Progr Neurobiol 68:361-376
2. Ransohoff RM, Howe CL, Rodriguez M (2002) Growth factor treatment of demyelinating diseases: at last, a leap into the light. Trends Immunol 23:512-516
3. Kerschensteiner M, Stadelmann C, Dechant G et al (2003) Neurotrophic cross-talk between the nervous and immune systems: implications for neurological diseases. Ann Neurol 53:292-304
4. Casaccia-Bonnefil P, Carter BD, Dobrowsky RT et al (1996) Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p 75. Nature 383:716-719
5. Micera A, Properzi F, Triaca V, Aloe L (2000) Nerve growth factor antibody exacerbates neuropathological signs of experimental autoimmune encephalomyelitis in adult Lewis rats. J Neuroimmunol 104:116-123
6. Villoslada P, Hauser SL, Bartke I et al (2000) Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system. J Exp Med 191:1799-1806
7. Stadelmann C, Kerschensteiner M, Misgeld T et al (2002) BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells? Brain 25:75-85
8. Webster HD (1997) Growth factors and myelin regeneration in multiple sclerosis. Mult Scler 3:113-120
9. Franklin RJM (2002) Why does remyelination fails in multiple sclerosis? Nat Rev Neurosci 3:705-714
10. Frank JA, Richert N, Lewis B et al (2002) A pilot study of recombinant insulin-like growth factor-I in seven multiple sclerosis patients. Mult Scler 8:24-29
11. Ruffini F, Furlan R, Poliani PL et al (2001) Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice. Gene Ther 8:1207-1213
12. Butzkueven H, Zhang JG, Soilu-Hanninen M et al (2002) LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival. Nat Med 8:613-619
13. Linker RA, Mäurer M, Gaupp S et al (2002) CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation. Nat Med 8:620-624
14. Giess R, Mäurer M, Linker R et al (2002) A null mutation in the CNTF gene is associated with early onset of multiple sclerosis. Arch Neurol 59:407-409
15. Cannella B, Hoban CJ, Gao YL et al (1998) The neuregulin, glial growth factor 2, diminishes autoimmune demyelination and enhances remyelination in a chronic relapsing model for multiple sclerosis. Proc Natl Acad Sci USA 95:10100-10105
16. Viehover A, Miller RH, Park SK et al (2001) Neuregulin: an oligodendrocyte growth factor absent in multiple sclerosis lesions. Dev Neurosci 23:377-386